Skip to main content
. 2021 Oct 13;15(3):460–468. doi: 10.1007/s12602-021-09858-5

Fig. 2.

Fig. 2

Survival curves for patients with coronavirus disease (COVID-19) who received the probiotic (dotted line) and those who did not (control group) (solid line): (a) all patients, (b) patients with cardiovascular diseases, and (c) patients with diabetes mellitus